ProQR Therapeutics (PRQR) Reiterated at Market Outperform by Citizens on AX-0810 Potential

March 13, 2026 6:28 AM

Citizens analyst Jonathan Wolleben reiterated a Market Outperform rating and $8.00 price target on ProQR Therapeutics N.V. (NASDAQ: PRQR).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found